Beyond Hormones: Investigating the Impact of Progesterone Receptor Membrane Component 1 in Lung Adenocarcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Progesterone Receptor Membrane Component 1 (PGRMC1) drives lung adenocarcinoma (LUAD) cell proliferation and migration by influencing WNT signaling. Higher PGRMC1 expression correlates with decreased patient survival in LUAD.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Progesterone Receptor Membrane Component 1 (PGRMC1) is implicated as an oncogene in various cancers.
- Its role in non-small cell lung cancer, specifically lung adenocarcinoma (LUAD), requires further elucidation.
Purpose Of The Study
- To investigate the influence of PGRMC1 on WNT signaling pathways in LUAD.
- To determine the impact of PGRMC1 on LUAD cell proliferation and migration.
Main Methods
- Computational analysis of gene expression datasets (GSE27262; GSE18842) and survival data.
- In vitro gene silencing of PGRMC1 in LUAD cells.
- Real-time PCR and Western blot for gene and protein expression analysis.
- Cell migration and spheroid formation assays.
Main Results
- PGRMC1 gene expression is elevated in LUAD tissues compared to normal tissues.
- Increased PGRMC1 expression is associated with reduced patient survival in LUAD.
- PGRMC1 gene silencing significantly affected WNT1, WNT5A, and WNT11 expression.
- PGRMC1 silencing reduced LUAD cell migration and spheroid formation.
- Experimental data confirmed a strong link between PGRMC1 and WNT5A expression in LUAD.
Conclusions
- PGRMC1 plays a crucial role in promoting LUAD progression by modulating WNT signaling.
- PGRMC1 is a potential therapeutic target for lung adenocarcinoma.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...